AI beats the clock: new platform could speed up heart attack diagnosis
NCT ID NCT06939738
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an artificial intelligence platform called Willem that analyzes electrocardiograms (ECGs) to detect heart attacks. Researchers will compare how fast and accurately the AI spots heart attack patterns versus human doctors. The study involves 500 adults who have had a heart attack and will look at whether the AI can speed up diagnosis and treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Willem (AI-powered ECG analysis platform)
What this could lead to
If successful, this AI could help doctors diagnose heart attacks faster and more accurately, potentially saving lives by speeding up treatment.
What could go wrong
This is an observational study, not a treatment trial. The AI may not perform better than human experts in real-world settings, and results may not apply to all hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Germans Trias i Pujol University Hospital
RECRUITINGBarcelona, 08916, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital General Universitario Gregorio Marañón
RECRUITINGMadrid, 28007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
La Paz University Hospital
RECRUITINGMadrid, 28046, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unidade Local de Saúde de Lisboa Ocidental
RECRUITINGLisbon, 1449-005, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unidade Local de Saúde de São José
RECRUITINGLisbon, 1169-056, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••